Study Results: OrthoTrophix TPX-100 in Knee OA

OrthoTrophix announced results of the first proof of principle study of TPX-100 in subjects with bilateral knee osteoarthritis, showing improvements at 6 and 12 months in key knee-related outcome measures.

TPX-100 is an injectable cartilage repair therapeutic agent. Initiated in 2014, the Phase II clinical trial evaluated intra-articular...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us